In October, 2020, we had a national WMFC meeting (via Zoom, of course). Our guest was Dr. Steve Treon of DFCI. The topic of his presentation was "Genomic and Treatment Advances in WM". The recording of the meeting is available, below. Genomic and Treatment Advances in WM
In an interview with OncLive in September, 2020, Dr. Treon from DFCI discussed the various BTK inhibitors that are now available or in trials. BTK Inhibitors transform WM management Along the same lines, a very valuable discussion was moderated by Dr. Treon, including experts from Europe and Australia. This was recorded for the Oncology Learning Network in 2019. It is available as both a video and as a transcript. Video: BTK Inhibitors for the treatment of WM Transcript: BTK Inhibitors for the treatment of WM
This animated video from Doc Mike Evans explains the effects of cancer-related fatigue. Dr. Evans explains that fatigue is the most common medical issue for cancer patients, ranking higher than pain or depression. He shares that cancer fatigue is very different than the fatigue most people face when they’re overtired or stressed, and that it has a profound effect on a person’s physical and mental health. Cancer-related fatigue can be brought on by a combination of things: the cancer itself, the side effects of cancer treatments like chemotherapy and radiotherapy, and depression or anxiety associated with having a chronic illness. [...]
The website "Patient Power" recently (Sept.-Nov., 2020) published a number of interviews, both as video and as transcripts. With Dr. Ansell from the Mayo Clinic: Will there be a cure for WM? With Dr. Treon from DFCI: Are we close to a cure for WM With Dr. Treon: How are BTK Inhibitors Changing WM outcomes With Dr. Treon: When should a patient seek treatment for WM
